LDHA and lung cancer: Moreover, considering our results and the potential of NSAIDs to target multiple glycolysis-related proteins, it would be interesting to test these drugs in tumours where Ldha inhibition has proven successful in preclinical studies, such as pancreatic and lung cancers.